Skip to content

LP Coil System RBYLP0204-BRecalls & reported problems

Penumbra, Inc. · Ruby Coil LP, 2 mm x 4 cm · Class 2 · Implant

All models of LP Coil System (38)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00815948025981), received between May 30, 2024 and Jul 18, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Premature Separation” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Premature Separation2
  • Fracture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 18, 2025Fracture; Premature Separation; Fracture; Premature Separation

    THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN A DISTAL GI ARTERY USING A RUBY COIL LP AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE RUBY COIL LP WAS ADVANCED INTO THE TARGET VESSEL WITH HALF OF THE COIL IN THE MICROCATHETER. THE EMBOLIZATION COIL THEN FRACTURED. IT WAS REPORTED THAT THE REMAINING SEGMENT OF RUBY COIL LP WAS IN THE MICROCATHETER WHEN THE EMBOLIZATION COIL FRACTURED. THE PHYSICIAN RETRACTED THE PUSHER ASSEMBLY WHEN THE REMAINDER OF THE EMBOLIZATION COIL UNINTENTIONALLY DETACHED FROM ITS PUSHER ASSEMBLY. THE PHYSICIAN THEN USED SALINE TO PUSH THE DETACHED EMBOLIZATION COIL FROM THE MICROCATHETER INTO THE TARGET VESSEL. THE PROCEDURE WAS CONSIDERED COMPLETED. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22546282 ↗
  • MalfunctionMay 30, 2024Premature Separation; Premature Separation

    THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE PROSTATE ARTERY USING A RUBY COIL LP, A NON-PENUMBRA MICROCATHETER, AND A GUIDEWIRE. IT WAS REPORTED THAT THE PATIENT¿S ANATOMY WAS TORTUOUS. DURING THE PROCEDURE, WHILE ADVANCING A RUBY COIL LP THROUGH THE MICROCATHETER, THE RUBY COIL LP UNINTENTIONALLY DETACHED WITHIN THE MICROCATHETER, THEREFORE, THE MICROCATHETER CONTAINING THE DETACHED RUBY COIL LP WAS REMOVED FROM THE PATIENT AND THE MICROCATHETER WAS FLUSHED. THE PROCEDURE WAS COMPLETED USING A NEW RUBY COIL LP AND A NEW NON-PENUMBRA MICROCATHETER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19431964 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page